Bradycardia, a medical condition characterized by a heart rate slower than the typical range, presents unique challenges and considerations in healthcare. Often defined by a heart rate falling below 60 beats per minute, bradycardia can manifest due to diverse factors, including aging, cardiac damage, or the use of certain medications. While some individuals may remain asymptomatic, others may experience sensations of fatigue, dizziness, or lightheadedness. The potential complications of severe bradycardia underscore the importance of timely diagnosis through methods such as electrocardiograms (ECGs), which evaluate the heart's electrical activity. Treatment approaches are diverse and contingent on the underlying cause, encompassing lifestyle adjustments, pharmacological interventions, and, in critical instances, the implantation of a pacemaker to regulate heart rate. Maintaining regular monitoring and seeking guidance from healthcare professionals is paramount for individuals managing bradycardia, ensuring proactive management and mitigation of potential health risks associated with this condition.
Title : Personalized and precision medicine (PPM) as a unique healthcare model through biodesign-driven translational applications and cardiology-related healthcare marketing to secure the human healthcare and biosafety
Sergey Suchkov, N.D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences, Russian Federation
Title : Beyond weight loss and diabetes control GLP 1 agonists paradigm shift in Cardiovascular care .
Syed Raza, Awali Hospital, Bahrain
Title : Vericiguat Inhibits the Progress of Cardiac Hypertrophy and Prevents Hypertrophy Induced Heart Failure by Multiple Mechanisms
Guo Wei He, TEDA International Cardiovascular Hospital, Tianjin University, China
Title : Coronary revascularization in patients with diabetes: Prospects for stenting in patients with type 1 diabetes and coronary artery disease
Mekhman N Mamedov, National Research Center for Therapy and Preventive Medicine, Russian Federation
Title : STEMI versus acute occlusive myocardial infarction: Which term should we use?
Yochai Birnbaum, Baylor College of Medicine, United States
Title : Chronic angina and the health economics of cardiovascular risk reduction in macro- and microvascular coronary disease
Uwe Peter Tigor, Auxilius Pharma, United States